CurrentCardio coverage · page 2 of 3
JACC: CardioOncology
Latest from JACC: CardioOncology
JACC CardioOncol
JACC CardioOncol
Multicohort Epigenome-Wide Association Study of All-Cause Cardiovascular Disease and Cancer Incidence: A Cardio-Oncology Approach
Meta-analysisCardio-oncology & other
JACC CardioOncol
Adiposity and Muscle Strength in Men With Prostate Cancer and Cardiovascular Outcomes
Cohort studyCardio-oncology & other
JACC CardioOncol
Preventing Cardiac Damage in Patients Treated for Breast Cancer and Lymphoma: The PROACT Clinical Trial
Randomised controlled trialCardio-oncology & other
JACC CardioOncol
Life’s Essential 8 and Incident Cardiovascular Disease in U.S. Women With Breast Cancer
Cohort studyCardio-oncology & other
JACC CardioOncol
Cardiac Substructure Radiation Dose and Associations With Tachyarrhythmia and Bradyarrhythmia After Lung Cancer Radiotherapy
Cohort studyCardio-oncology & other
JACC CardioOncol
Baseline Cardiac Parameters as Biomarkers of Radiation Cardiotoxicity in Lung Cancer: An NI-HEART Analysis
Cohort studyCardio-oncology & other
JACC CardioOncol
Deep Inspiration Breath Hold in Left-Sided Breast Radiotherapy: A Balance Between Side Effects and Costs
Research articleCardio-oncology & other
JACC CardioOncol
Neighborhood Archetypes and Cardiovascular Health in Black Breast Cancer Survivors
Cohort studyCardio-oncology & other
JACC CardioOncol
Social Determinants of Health Mediate Racial Disparities in Cardiovascular Disease in Men With Prostate Cancer
Cohort studyCardio-oncology & other
JACC CardioOncol
JACC CardioOncol
Neighborhood Walkability Is Associated With Lower Burden of Cardiovascular Risk Factors Among Cancer Patients
Cross-sectional studyCardio-oncology & other
JACC CardioOncol
Atrial Fibrillation as a Prognostic Factor for All-Cause Mortality in Patients With Transthyretin Amyloid Cardiomyopathy
Secondary analysisHeart failure
JACC CardioOncol
A Biomarker-Based Diagnostic Model for Cardiac Dysfunction in Childhood Cancer Survivors
Diagnostic or prognostic studyCardio-oncology & other
JACC CardioOncol
JACC CardioOncol
JACC CardioOncol
Arterial Thromboembolism in Japanese Patients With Cancer: Incidence, Predictors, and Survival Impact
Cohort studyCardio-oncology & other
JACC CardioOncol
Cardiovascular Eligibility Criteria and Adverse Event Reporting in Combined Immune Checkpoint and VEGF Inhibitor Trials
Randomised controlled trialCardio-oncology & other
JACC CardioOncol
Clinical Outcomes Among Immunotherapy-Treated Patients With Primary Cardiac Soft Tissue Sarcomas: A Multicenter Retrospective Study
Cohort studyCardio-oncology & other
JACC CardioOncol
Impact of the ESC Cardio-Oncology Guidelines Biomarker Criteria on Incidence of Cancer Therapy–Related Cardiac Dysfunction
Secondary analysisCardio-oncology & other
JACC CardioOncol
Heart Failure Readmission in Patients With ST-Segment Elevation Myocardial Infarction and Active Cancer
Cohort studyCoronary & ACS
JACC CardioOncol
Comparing Anticoagulation Strategies for Venous Thromboembolism Associated With Active Cancer: A Systematic Review and Meta-Analysis
Meta-analysisPulmonary vascular & VTE
JACC CardioOncol
Severe vs Nonsevere Immune Checkpoint Inhibitor-Induced Myocarditis: Contemporary 1-Year Outcomes
Cohort studyCardio-oncology & other
JACC CardioOncol
Cancer-Associated Thrombosis: Trends in Clinical Features, Treatment, and Outcomes From 2001 to 2020
Cohort studyCardio-oncology & other
JACC CardioOncol
Associations Between Social Determinants of Health and Cardiovascular Health of U.S. Adult Cancer Survivors
Cross-sectional studyCardio-oncology & other
JACC CardioOncol
Cardiovascular Toxicities of BTK Inhibitors in Chronic Lymphocytic Leukemia: JACC: CardioOncology State-of-the-Art Review
Research articleCardio-oncology & other
JACC CardioOncol
Incorporating Exercise Training into Cardio-Oncology Care: Current Evidence and Opportunities: JACC: CardioOncology State-of-the-Art Review
Research articleCardio-oncology & other
JACC CardioOncol
Incidence of MACE in Patients Treated With CAR-T Cell Therapy: A Prospective Study
Cohort studyCardio-oncology & other
JACC CardioOncol
Predicting Adverse Cardiac Events After Radiotherapy for Locally Advanced Non–Small Cell Lung Cancer
Cohort studyCardio-oncology & other
JACC CardioOncol
Increased Cardiac Risk After a Second Malignant Neoplasm Among Childhood Cancer Survivors: A FCCSS Study
Cohort studyCardio-oncology & other
JACC CardioOncol
Cardiovascular Events After Hematopoietic Stem Cell Transplant: Incidence and Risk Factors
Cohort studyCardio-oncology & other
JACC CardioOncol
Gene-Level Analysis of Anthracycline-Induced Cardiomyopathy in Cancer Survivors: A Report From COG-ALTE03N1, BMTSS, and CCSS
Case-control studyCardio-oncology & other
JACC CardioOncol
The Association of Metformin With Heart Failure in Patients With Diabetes Mellitus Receiving Anthracycline Chemotherapy
Cohort studyCardio-oncology & other
JACC CardioOncol
Chest Pain in Cancer Patients: Prevalence of Myocardial Infarction and Performance of High-Sensitivity Cardiac Troponins
Diagnostic or prognostic studyCardio-oncology & other
JACC CardioOncol
Extensive Cardiac Function Analyses Using Contemporary Echocardiography in Childhood Cancer Survivors: A DCCSS LATER Study
Cross-sectional studyCardio-oncology & other
JACC CardioOncol
Cardiovascular Effects of GnRH Antagonists Compared With Agonists in Prostate Cancer: A Systematic Review
Meta-analysisCardio-oncology & other
JACC CardioOncol
Anticoagulation for the Prevention of Arterial Thrombosis in Ambulatory Cancer Patients: Systematic Review and Meta-Analysis
Meta-analysisCardio-oncology & other
JACC CardioOncol
Cardiotoxicity of BRAF/MEK Inhibitors: A Longitudinal Study Incorporating Contemporary Definitions and Risk Scores
Cohort studyCardio-oncology & other
JACC CardioOncol
JACC CardioOncol